INTRODUCTION
Celiac disease (CD) is an autoimmune disorder triggered by intestinal exposure to gluten, a protein commonly found in wheat, barley and rye. Typical manifestation of CD consists of early onset of malabsortion-related symptoms, while atypical forms of the disease are commonly diagnosed during adulthood and frequently related to extra-intestinal manifestations (8) . Several extra-intestinal features have been associated with CD, such as metabolic osteopathy, anemia, and dermatitis herpetiformis (23) . There has been evidence indicating a link between CD and reproductive disorders, such as recurrent abortions (3) . The relationship between CD and infertility has been previously assessed by several studies, with contradictory results (13, 20) . Hence, we sought to perform a systematic review and meta-analysis of current evidence on this particular subject.
recommendations of the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group (28) . Controlled studies with case-control or cohort study designs were considered for review. Uncontrolled observational studies and case series were excluded. Two kinds of studies were analyzed in-depth: those assessing the risk of infertility in subjects with previously diagnosed CD, and those evaluating the prevalence of undiagnosed CD in subjects already diagnosed with infertility.
Search strategy
A computer-assisted search was performed from 1966 to December 2013 in the MEDLINE-Pubmed, EMBASE, LILACS and Cochrane Library databases. The search strategy consisted of the MESH terms "celiac disease" or "celiac sprue" and "infertility" or "genital diseases, female" or "sterility". There was no language restriction. We reviewed the bibliography of identified relevant papers. Additionally, abstracts from Digestive Disease Week and United European Gastroenterology Week 2008-2013 were manually reviewed.
Two authors independently performed the bibliographic search for potentially relevant studies. Compatible abstracts were reviewed to check compliance with eligibility criteria. The findings of each author were then compared. If there was disagreement towards a particular study, its inclusion was decided by a third author.
If there was evidence of duplicated data, original papers' authors were contacted in order to determine study inclusion or exclusion.
Quality assessment
Methodological quality of included studies was evaluated by two authors in an independent manner using the Newcastle-Ottawa assessment scale for case-control and cohort studies (27) . If disagreement on a particular subject was encountered, a third author resolved the difference.
Statistical analysis
Meta-analysis was performed using REVMAN software (Review Manager Version 5.1. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration, 2011). Heterogeneity was evaluated using the I2 and chi square test. Because of anticipated variability in patient population and study design, a random-effect model was used. The first analysis included studies assessing the occurrence of non-diagnosed CD in patients suffering from infertility; the outcome was described as an Odds Ratio (OR) with a 95% confidence interval (95% CI). In a second analysis, we included studies evaluating the odds of infertility in patients previously diagnosed with CD. We also used an OR with a 95% CI in order to describe the latter. Sensitivity analysis was performed according to heterogeneity or if significant methodological quality differences were found. Funnel plots were performed in order to assess potential publication bias.
RESULTS
The search identified 413 bibliographic citations. Of these, 395 were excluded, and eighteen potentially relevant studies were evaluated. Six studies were excluded because they did not fulfilled elegibility criteria: three studies lacked a control group (5, 13, 17) , a large population-based study (9) was not designed to compare infertility prevalence in celiac subjects and used U.S. general population as a control group; another study (20) used an inadequate control group (previously known prevalence of silent CD in the northen Sardinian population) and another one (7) assessed the risk of infertility only in male subjects and used Crohn's disease patients as control group. Finally, as shown in Figure 1 , twelve studies were included for analysis. Two of the analyzed studies were population-based cohort studies (Zugna 2010 and Tata 2005) which evaluated the risk of infertility in a CD population (29, 31) . Two other studies (Molteni 1990 and Sher 1994) were case-control studies evaluating the odds of infertility in a CD group compared to a non-celiac control group (21, 25) . Finally, eight studies (Collin 1996 assessed the occurrence of non-diagnosed CD in subjects suffering from infertility compared to apparently healthy controls (4, 6, 12, 14, 15, 16, 24, 30) . Two studies included data on male partners also evaluated for non-diagnosed CD versus controls (Khoshbaten 2011 , Hogen Esch 2011 .
Characteristics of included studies are summarized in Table 1 . Infertility was assessed in a similar fashion in most studies; however, this was not clearly stated in the studies by Methodological assessment of included studies is described in Table 2 . No study was excluded due to methodological limitations.
Non-diagnosed celiac disease in subjects with infertility
Meta-analytical findings of the first condition are described in Table 3 . Overall, 4471 subjects were included in this analysis. No heterogeneity was observed (I2 0%; P 0.67), and a significant association was found between women with a diagnosis of infertility and CD [OR 3.09 (95% CI 1.74-5.49)]. Sensitivity analysis was also performed; studies assessing all kinds of infertility (not only UI) were also excluded. No relevant differences were found as a result [OR3.41 (1.65-7.03)]. Further sensitivity analysis was carried out by excluding studies that did not use anti-transglutaminase and/or anti-endomysium antibodies for initial CD screening (Collin 1996) ; again, no significant difference was found in the result [OR 2.95 (1.64-5.31)].
Meta-analysis of studies which evaluated CD in male partners versus control subjects included 2054 patients and Total events 9 7 Heterogeneity: Tau Total events 45 17 Heterogeneity: Tau Table 4 . Figure 2A shows the funnel plot of included studies mentioned above, with no significant asymmetry (Egger test, P = 0.3).
Infertility in subjects with diagnosed celiac disease
When considering studies assessing the occurrence of infertility in subjects with CD, 33636 subjects were included for analysis. No difference was found between CD patients and control subjects [OR 0.99 (95% CI 0.86-1.13)], as described in Table 5 . Significant heterogeneity was corrected by the exclusion of one of the studies (Sher 1994 ), which did not alter the result of the analysis [OR 0.97 (0.92-1.03)]. Figure 2B shows funnel plot of these studies, with an asymmetry that could be related to a publication bias (Egger test, P<0.001).
DISCUSSION
Our meta-analysis evaluates the association between a frequent reproductive disorder such as infertility and CD.
According to our results, non-diagnosed untreated CD constitutes a risk factor significantly associated with infertility in women. When comparing studies that enrolled patients previously diagnosed with CD, this association is not as evident as in the former context. This could be related to the effect that adoption of a gluten-free diet (GFD) may have on this particular health issue.
The association between CD and female reproductive disorders has been previously described (3) . It is well known that CD increases the risk of recurrent miscarriages, low weight at birth, early menopause and other pregnancy disorders (10, 11, 18, 19, 26) . It is also known that these kinds of complications appear to diminish once a GFD is implemented.
Infertility is defined as the impossibility of conceiving after 12 months of unprotected intercourse (1) . It can be related to both male and female factors, with the latter subdivided into ovarian, tubal, endometrial or unexplained causes. It is relatively frequent, with approximately 8%-12% of couples with women at child-bearing age carrying this condition (2) . 
A B
Reports on infertility risk in CD patients are far from scarce, but often show non-definite, sometimes conflicting results. Jackson et al. (13) described a cohort of women suffering from infertility that were tested for CD by means of serology. This study found a relatively low frequency of CD among infertile women compared to the background rate in the general U.S. population. Choi et al. (5) tested women assisting at an infertility clinic for CD; although an increased prevalence overall was not found, CD was more frequent in those women with UI; again, this study lacked a control group.
Case-control and cross-sectional studies assessing the risk of CD in infertile patients also show conflicting results. The largest study published by Hogen Esch et al. (12) included 1038 patients attending to an infertility clinic and 1432 controls. They did not find a significant difference in CD prevalence between groups; it is worth mentioning though that they only performed serological tests to determine CD prevalence. Da Silva Martins et al. (6) published the only experience so far in a South-American setting: they included 200 patients attending an infertility clinic and 400 control subjects. They also were not able to find a significant CD prevalence among infertile women.
Only the study by Kumar et al. (16) proved a significant association between CD and infertility. The other studies included in this analysis did not reach a statistically relevant difference, probably due to insufficient sample size. However, as revealed in our meta-analysis, the pooled OR is significantly increased.
These results contrast with those derived from cohort and case-control studies including previously diagnosed CD subjects. Tata et al. (29) published a large cohort study that assessed 1521 CD women in fertile age and 7732 non-CD women matched by age, sex, general practice and follow-up time. They found that the birth rates in both groups with a similar median follow-up time (4.3 vs 4.9 years) were similar (HR 1.01 95%CI 0.91-1.14). What is more, Zugna et al. (31) published an even larger cohort study including 11495 women with CD and 51109 controls: they also did not find en excessive risk of infertility in the CD cohort. These results contrast with those from studies that included non-diagnosed CD. A potential explanation for this difference may be that in the cohort studies, CD patients were already treated: this may underline that GFD may cause a reversal of infertility problems in celiac women. Cohort studies including alreadydiagnosed CD women did not assess GFD compliance, so it is not possible to conclude that gluten ingestion may actually be a risk factor for developing infertility in CD subjects. However, Zugna et al. (31) found that although women with CD had normal fertility overall, fertility levels decreased in the last two years preceding CD diagnosis. This emphasizes the fact that untreated CD is a risk factor for infertility and that GFD may be sufficient to correct this abnormality.
There is no clear explanation why these two entities are associated. CD is associated with many extra-intestinal diseases that have an immunological basis. Persistent inflammation can produce some serological markers that may have an impact in the development of infertility (22) . As seen with other extra-intestinal diseases, early introduction of a GFD may decrease the risk of this complication. Further studies should focus on this particular subject.
Although evidence is relatively scarce, studies evaluating male partners failed to show a significant association between infertility and CD. However, these studies do not mention a relationship between CD and certain factors related to male infertility, such as hypogonadism or semen quality deficiencies. Farthing et al. (7) described a high frequency of seminal alterations and sexual dysfunction in a cohort of CD male patients compared to Crohn's disease subjects.
Limitations must be taken into consideration. Among all of the studies analyzed, heterogeneity in CD definition and serological tests used for screening were found. Most of them, however, required histological confirmation. Secondly, the impact that GFD may exert cannot be estimated due to the design of included studies. Furthermore, the impact of poor adherence to GFD cannot be calculated from available evidence. Although funnel plot analysis doesn't suggest a significant publication bias when considering studies assessing CD risk in subjects with infertility, there is a significant asymmetry in the funnel plot of studies assessing risk of infertility in already-diagnosed CD patients.
In conclusion, this meta-analysis shows that undiagnosed CD is in fact a risk factor for infertility. This may have a significant impact on the management of infertility, since women seeking medical advice for this particular condition should be screened for CD. Ultimately, adoption of a GFD could have a positive impact on fertility in this group of patients.
